Roche’s Herceptin Captures Turkey’s Top Import Branded Drug In 2013
This article was originally published in PharmAsia News
Executive Summary
Roche’s cancer drug Herceptin is at the top of the list of reimbursed imported brands with TL 135.1 million ($61.1 million) in sales. Turkey’s pharmaceutical imports grew by 3.3 % in 2013 and reached TL 9.76 billion ($4.49 billion).